Targeting the Microbiome With KB109 in Outpatients with Mild to Moderate COVID-19 Reduced Medically Attended Acute Care Visits and Improved Symptom Duration in Patients With Comorbidities
Haran et al., medRxiv, doi:10.1101/2021.03.26.21254422
https://c19early.org/haran.html